ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician
Scientist and Academic Leader
BROOMFIELD, Colo. -- May 6, 2013
ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that Burton E. Sobel, 75,
a member of its Board of Directors, has died.
“Burt was recognized as one of the great academic physicians of our time. He
did groundbreaking work in several fields of cardiovascular medicine including
blood coagulation, which led to major advances in the treatment of heart
attacks and other thromboembolic diseases, as well as seminal work on
myocardial function and biochemistry in response to hemodynamic stress. Burt
will be deeply missed by his family, friends, colleagues and the many patients
whose lives were greatly improved by his contributions to cardiovascular
medicine,” commented Michael Bristow, M.D., Ph.D., President and CEO of ARCA.
“All of us at ARCA are deeply saddened by his passing.”
Sobel was a Professor of Medicine and Biochemistry at the University of
Vermont, Director of the Cardiovascular Research Institute at the University,
and former Chairman of the Department of Medicine. Previously, he had held
academic and leadership positions at other major research institutions. Sobel
edited major cardiovascular and medical journals, and had over 800 manuscripts
published. He was active in the pharmaceutical industry as well, and had
served on several boards of directors in addition to ARCA. Sobel received
numerous awards, including a Research Career Development Award from the
National Institutes of Health, a Distinguished Scientist Award from the
American College of Cardiology and the Herric Award from the American Heart
Association. He was a magna cum laude graduate of the Harvard Medical School.
ARCA biopharma, Inc.
Derek Cole, 720-940-2163
Investor Relations Advisory Solutions
Press spacebar to pause and continue. Press esc to stop.